Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 872,423 | 585,979 | 272,277 | 173,781 | 128,449 |
| Cost of Goods | 102,146 | 78,425 | 13,942 | 13,559 | 9,638 |
| Gross Profit | 770,277 | 507,554 | 258,335 | 160,222 | 118,811 |
| Operating Expenses | 430,111 | 310,135 | 131,446 | 102,992 | 103,519 |
| Operating Income | 340,312 | 197,844 | 127,831 | 57,789 | 15,930 |
| Interest Expense | 26,916 | 16,869 | 1,600 | 12,724 | 22,796 |
| Other Income | -5,446 | -3,620 | -1,247 | -12,287 | 30 |
| Pre-tax Income | 307,950 | 177,355 | 124,984 | 32,778 | -6,836 |
| Income Tax | 91,638 | -83,794 | 0 | 0 | N/A |
| Net Income Continuous | 216,312 | 261,149 | 124,984 | 32,778 | -6,836 |
| Net Income Discontinuous | N/A | 27,437 | 0 | 0 | N/A |
| Net Income | $216,312 | $288,586 | $124,984 | $32,778 | $-6,836 |
| EPS Basic Total Ops | 3.71 | 5.09 | 3.01 | 0.90 | -0.23 |
| EPS Basic Continuous Ops | 3.71 | 4.61 | 3.01 | 0.90 | -0.23 |
| EPS Basic Discontinuous Ops | N/A | 0.48 | 0.00 | 0.00 | N/A |
| EPS Diluted Total Ops | 3.51 | 4.79 | 2.67 | 0.83 | -0.23 |
| EPS Diluted Continuous Ops | 3.51 | 4.34 | 2.67 | 0.83 | -0.23 |
| EPS Diluted Discontinuous Ops | N/A | 0.45 | 0.00 | 0.00 | N/A |
| EBITDA(a) | $426,993 | $272,073 | $135,658 | $66,500 | $25,027 |